R3 Vascular
Initial Transaction Details
Transaction Date
April 2024
Purpose of Financing
Venture
Stage of Company
Mid Stage
Structure of Financing
Equity
R3 Vascular is a privately-held medical device company that developed a novel technology platform for fully bioresorbable sirolimus coated vascular scaffolds that are designed to deliver the ‘stent-like’ support of a scaffold along with the anti-inflammatory result of sirolimus, but ‘disappearing’ over time as the vessel heals. R3 Vascular is headquartered in Mountain View, California.
Website